- Correction
- Open access
- Published:
Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells
Journal of Nanobiotechnology volume 16, Article number: 3 (2018)
The Original Article was published on 12 May 2014
Correction to: Journal of Nanobiotechnology 2014, 12:21 https://doi.org/10.1186/1477-3155-12-21
Following publication of our article [1], we became aware that Roberto Di Gesù had been omitted from the list of authors. The corrected author list and authors’ contribution statement appear below. We apologize for any inconvenience this may have caused.
Corrected author list
Roberto Di Gesù, Maria Luisa Bondì, Antonina Azzolina, Emanuela Fabiola Craparo, Chiara Botto, Erika Amore, Gaetano Giammona, Melchiorre Cervello
Corrected Authors’ contributions
CB and EA are the Ph.D. students who carried out the laboratory work. AA carried out the biological work in laboratory. MC was the supervisor of the biological study and helping to develop the study parameters and design. RDG performed principal and most important analysis in the chemical and pharmaceutical studies. He produced materials and analyzed data showed in this work. MLB was the principal, scientific supervisor of the study. She conceived the study, supervised the students in the laboratory, directed the analysis and wrote the manuscript. EFC and GG have revised the final version of manuscript. All authors read and approved the final manuscript.
Competing interests
The authors declare that they have no competing interests.
Reference
Di Gesù R, Bondì ML, Azzolina A, Craparo EF, Botto C, Amore E, Giammona G, Cervello M. Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells. Journal of Nanobiotechnology. 2014;12:21.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Author information
Authors and Affiliations
Corresponding author
Additional information
The original article can be found online at https://doi.org/10.1186/1477-3155-12-21.
Rights and permissions
Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
About this article
Cite this article
Di Gesù, R., Bondì, M.L., Azzolina, A. et al. Correction to: Entrapment of an EGFR inhibitor into nanostructured lipid carriers (NLC) improves its antitumor activity against human hepatocarcinoma cells. J Nanobiotechnol 16, 3 (2018). https://doi.org/10.1186/s12951-017-0325-y
Received:
Accepted:
Published:
DOI: https://doi.org/10.1186/s12951-017-0325-y